- Trials with a EudraCT protocol (38)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
38 result(s) found for: Pertussis toxin.
Displaying page 1 of 2.
| EudraCT Number: 2009-013411-36 | Sponsor Protocol Number: VTdaP-01 | Start Date*: 2009-12-08 | |||||||||||
| Sponsor Name:Statens Serum Institut | |||||||||||||
| Full Title: Immunogenicity and safety of a tetanus, diphtheria and mono component acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as a booster vaccination t... | |||||||||||||
| Medical condition: The intended use of the vaccine in this study is to increase the immunological protection against pertussis in adults who completed primary vaccination with diphtheria, tetanus and pertussis vaccin... | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-008195-13 | Sponsor Protocol Number: 2008-008195-13 | Start Date*: 2009-02-18 |
| Sponsor Name:Swedish Institute for Infectious Disease Control (SMI) | ||
| Full Title: An immunogenicity and safety study of combined adsorbed tetanus, low dose diphtheria and acellular pertussis vaccine (Td5ap and Td1aP) given as a school-leaving booster to 14-15-year-old children p... | ||
| Medical condition: Two vaccines against diphtheria, tetanus and pertussis will be tested and immune respons investigated in 14-15-year-old children primed with a five component acellular pertussis vaccine at 3, 5 and... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003838-32 | Sponsor Protocol Number: ADC01 | Start Date*: 2019-01-11 |
| Sponsor Name:Sanofi Pasteur | ||
| Full Title: Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults | ||
| Medical condition: Tetanus Diphtheria Pertussis | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003678-42 | Sponsor Protocol Number: IIV-316 | Start Date*: 2017-09-01 |
| Sponsor Name:RIVM [...] | ||
| Full Title: Immunological effects of an acellular pertussis booster vaccination in children, young adults and elderly with different immunisation background. An international study in Finland, the Netherlands... | ||
| Medical condition: Pertussis infection | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) FI (Completed) GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005532-27 | Sponsor Protocol Number: PERTIMMUN06 | Start Date*: 2006-02-07 |
| Sponsor Name:Sanofi Pasteur Inc. | ||
| Full Title: Comparison of Pertussis Specific Cellular and Humoral Immunity Before and After a Acellular Pertussis Booster-Vaccineation in Combination With a Diphtheria-Tetanus-Polio-Vaccine Between Three Group... | ||
| Medical condition: Prophylaxis | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-002452-40 | Sponsor Protocol Number: Td500056 | Start Date*: 2023-03-08 | ||||||||||||||||||||||||||
| Sponsor Name:Sanofi Pasteur | ||||||||||||||||||||||||||||
| Full Title: Immune Response to Pertussis after Vaccination with a Tdap-IPV Booster Vaccine in Children in the Republic of South Africa: Effect of Homologous and Heterologous Pertussis Vaccination Priming Backg... | ||||||||||||||||||||||||||||
| Medical condition: Bacterial infections | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: Outside EU/EEA | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2007-000199-17 | Sponsor Protocol Number: SM07-01 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Norwegian Institute of Public Health | ||
| Full Title: Open clinical study to assess the immune response and safety of a booster dose (5th dose) of a combination vaccine against diphteria-tetanus-pertussis-polio given to healthy adolescents 15-16 year... | ||
| Medical condition: Profylactic vaccination against diphteria-, tetanus-, pertussis and polio in healthy volunteers 15-16 years old. These volunteers have previously been given a 4th dose of the same vaccine in a clin... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NO (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-002976-41 | Sponsor Protocol Number: ZonMW522004008 | Start Date*: 2019-07-09 |
| Sponsor Name:RIVM | ||
| Full Title: ‘Premature infants and maternal pertussis immunization. Is second trimester vaccination beneficial?’ | ||
| Medical condition: women in their first trimester of pregnancy | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003466-39 | Sponsor Protocol Number: Protocol_MAMA_studie_22/05/2018 | Start Date*: Information not available in EudraCT |
| Sponsor Name:University of Antwerp | ||
| Full Title: Pertussis immunization during pregnancy: assessment of the role of maternal antibodies on immune responses in term and preterm infants (the MAMA study) | ||
| Medical condition: The effect of pertussis vaccination during pregnancy on the immune response after infant and childhood vaccinations in term and preterm infants. | ||
| Disease: | ||
| Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-000554-46 | Sponsor Protocol Number: 106786 | Start Date*: 2006-08-09 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase II, observer-blind, randomized study to evaluate the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ combined DSSITGDPa-HBV-IPV/Hib vaccine containing diphth... | ||
| Medical condition: Primary immunization of healthy infants in the first year of life against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Haemophilus influenzae type b diseases. | ||
| Disease: | ||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-001986-34 | Sponsor Protocol Number: T151/2019 | Start Date*: 2019-11-19 | |||||||||||
| Sponsor Name:Turku University Hospital | |||||||||||||
| Full Title: Exploring the impact of pertussis immunization during pregnancy on the differences in immune response of infants after primary immunization with an acellular pertussis containing vaccine: an open l... | |||||||||||||
| Medical condition: Pertussis Infection | |||||||||||||
|
|||||||||||||
| Population Age: In utero, Newborns, Infants and toddlers, Children, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-003136-23 | Sponsor Protocol Number: CYD66 | Start Date*: 2020-02-12 |
| Sponsor Name:Sanofi Pasteur SA | ||
| Full Title: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially with Adacel® in Healthy Subjects Aged 9 to 60 Years in the Philippines | ||
| Medical condition: Dengue Fever Dengue Hemorrhagic Fever | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2016-000274-37 | Sponsor Protocol Number: PRI03C | Start Date*: 2016-03-21 | ||||||||||||||||||||||||||||||||||||
| Sponsor Name:MCM Vaccine B.V. | ||||||||||||||||||||||||||||||||||||||
| Full Title: Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4- to 5 year old Children Previously Vaccinated with a 2-dose or 3-dose Infants series and Toddler dose with VAXELIS... | ||||||||||||||||||||||||||||||||||||||
| Medical condition: Vaxelis is indicated for primary and booster vaccination in infants and toddlers against diphtheria, tetanus, pertussis, hepatitis B (HB), poliomyelitis and invasive diseases caused by Haemophilus ... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
| Trial protocol: FI (Completed) | ||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2014-004177-16 | Sponsor Protocol Number: B1841007 | Start Date*: 2015-04-09 |
| Sponsor Name:Pfizer Japan, Inc. | ||
| Full Title: A Phase 4, Randomized, Open-Label Trial Evaluating the Safety, Tolerability, and Immunogenicity of DTaP Vaccine in Healthy Infants Given With a 7-valent Pneumococcal Conjugate Vaccine in Japan. | ||
| Medical condition: Prevention of disease caused by a type of bacteria called Streptococcus pneumoniae (pneumococcal disease). | ||
| Disease: | ||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2019-001789-13 | Sponsor Protocol Number: 2016/02 | Start Date*: 2020-01-13 | ||||||||||||||||
| Sponsor Name:Clinical Trials and Research Governance (CTRG), University of Oxford | ||||||||||||||||||
| Full Title: A randomised, open label study, exploring the differences in immunogenicity and reactogenicity of infants after immunisation with either an acellular (aP) or whole cell pertussis (wP) vaccine | ||||||||||||||||||
| Medical condition: This study is going to focus on the immunisations against pertussis disease in previous healthy children, but the disease itself is not going to be study. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2013-004495-34 | Sponsor Protocol Number: iMAP2 | Start Date*: 2014-03-11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:Public Health England | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: A randomised controlled trial comparing two pertussis-containing vaccines in pregnancy and vaccine responses in UK mothers and their infants (immunising Mums Against Pertussis, iMAP2) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: No medical condition or disease, instead responses to immunisations against pertussis (whooping cough) in mothers and against pertussis (whooping cough), tetanus, diphtheria, Hib, meningococcal C a... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2021-005194-77 | Sponsor Protocol Number: Matimmunestudyversion2 | Start Date*: 2021-10-26 |
| Sponsor Name:University of Antwerp | ||
| Full Title: The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women | ||
| Medical condition: humoral and cellular immune responses to pertussis vaccine during pregnancy | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: BE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-001936-45 | Sponsor Protocol Number: matab4 | Start Date*: 2011-05-25 |
| Sponsor Name: | ||
| Full Title: Pertussis vaccination in pregnancy | ||
| Medical condition: The number of reported pertussis cases is rising, also in very young infants. Different strategies are possible to close the gap of susceptibility between the loss of maternal antibodies and prote... | ||
| Disease: | ||
| Population Age: In utero, Newborns, Infants and toddlers, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-003248-31 | Sponsor Protocol Number: 110806 | Start Date*: 2007-11-16 |
| Sponsor Name:GSK Biologicals | ||
| Full Title: An open, phase IV, non-randomised, single-centre study with two study groups to assess the immunogenicity and reactogenicity of a booster dose of GlaxoSmithKline (GSK) Biologicals' combined reduced... | ||
| Medical condition: Booster vaccination against diphtheria, tetanus and pertussis diseases in adults | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-003477-94 | Sponsor Protocol Number: 110947 | Start Date*: 2008-02-13 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase IV, open, non-randomised, multicentre study to assess the reactogenicity and immunogenicity of a booster dose of GSK Biologicals’ combined reduced-antigen-content diphtheria-tetanus, acellu... | ||
| Medical condition: Booster immunisation against diphtheria, tetanus, pertussis and poliomyelitis diseases in children and adolescents. | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
